Literature DB >> 24684372

Glucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibition.

Melanie Y Vincent1, Lauren Jacobson.   

Abstract

Glucocorticoids can cause depression and anxiety. Mechanisms for glucocorticoid effects on mood are largely undefined. The dorsal raphé nucleus (DRN) produces the majority of serotonin in the brain, and expresses glucocorticoid receptors (GR). Because we previously showed that antidepressants used to treat depression and anxiety decrease DRN GR expression, we hypothesized that deleting DRN GR would have anxiolytic- and antidepressant-like effects. We also hypothesized that DRN GR deletion would disinhibit activity of the hypothalamic-pituitary-adrenal (HPA) axis. Adeno-associated virus pseudotype AAV2/9 expressing either Cre recombinase (DRNGRKO mice) or GFP (DRN-GFP mice) was injected into the DRN of floxed GR mice to test these hypotheses. Three weeks after injection, mice underwent 21 days of social defeat or control handling and were tested for anxiety-like behavior (open-field test, elevated-plus maze), depression-like behavior [sucrose preference, forced-swim test (FST), tail-suspension test (TST)], social interaction, and circadian and stress-induced HPA activity. DRN GR deletion decreased anxiety-like behavior in control but not in defeated mice. DRN GR deletion decreased FST and tended to decrease TST despair-like behavior in both control and defeated mice, but did not affect sucrose preference. Exploration of social (a novel mouse) as well as neutral (an empty box) targets was increased in DRNGRKO mice, suggesting that DRN GR deletion also promotes active coping. DRN GR deletion increased stress-induced HPA activity without strongly altering circadian HPA activity. We have shown a novel role for DRN GR to mediate anxiety- and despair-like behavior and to regulate HPA negative feedback during acute stress.
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  anxiety; corticosterone; depression; serotonin; stress

Mesh:

Substances:

Year:  2014        PMID: 24684372      PMCID: PMC4028415          DOI: 10.1111/ejn.12538

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  72 in total

Review 1.  The psychiatric side effects of corticosteroids.

Authors:  E S Brown; D A Khan; V A Nejtek
Journal:  Ann Allergy Asthma Immunol       Date:  1999-12       Impact factor: 6.347

Review 2.  Assessing antidepressant activity in rodents: recent developments and future needs.

Authors:  John F Cryan; Athina Markou; Irwin Lucki
Journal:  Trends Pharmacol Sci       Date:  2002-05       Impact factor: 14.819

Review 3.  Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis.

Authors:  C A Lowry
Journal:  J Neuroendocrinol       Date:  2002-11       Impact factor: 3.627

Review 4.  The neuropharmacology of serotonin and noradrenaline in depression.

Authors:  David J Nutt
Journal:  Int Clin Psychopharmacol       Date:  2002-06       Impact factor: 1.659

Review 5.  Corticosteroids in relation to fear, anxiety and psychopathology.

Authors:  S M Korte
Journal:  Neurosci Biobehav Rev       Date:  2001-03       Impact factor: 8.989

6.  Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.

Authors:  A W Zobel; T Nickel; A Sonntag; M Uhr; F Holsboer; M Ising
Journal:  J Psychiatr Res       Date:  2001 Mar-Apr       Impact factor: 4.791

Review 7.  Steroid psychosis: a review.

Authors:  François Sirois
Journal:  Gen Hosp Psychiatry       Date:  2003 Jan-Feb       Impact factor: 3.238

8.  Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase.

Authors:  Etienne Thévenot; Francine Côté; Philippe Colin; Yi He; Hélène Leblois; Michel Perricaudet; Jacques Mallet; Guilan Vodjdani
Journal:  Mol Cell Neurosci       Date:  2003-09       Impact factor: 4.314

9.  Neuroendocrine profiles in mood disorders.

Authors:  Paul Linkowski
Journal:  Int J Neuropsychopharmacol       Date:  2003-06       Impact factor: 5.176

Review 10.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Authors:  Meera Vaswani; Farzana Kadar Linda; Subramanyam Ramesh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

View more
  12 in total

1.  Dorsal raphé nucleus glucocorticoid receptors inhibit tph2 gene expression in male C57BL/6J mice.

Authors:  Melanie Y Vincent; Nina C Donner; David G Smith; Christopher A Lowry; Lauren Jacobson
Journal:  Neurosci Lett       Date:  2017-11-22       Impact factor: 3.046

Review 2.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

3.  Motherhood and infant contact regulate neuroplasticity in the serotonergic midbrain dorsal raphe.

Authors:  M Allie Holschbach; Joseph S Lonstein
Journal:  Psychoneuroendocrinology       Date:  2016-11-19       Impact factor: 4.905

Review 4.  Genetic Approaches to Hypothalamic-Pituitary-Adrenal Axis Regulation.

Authors:  Melinda G Arnett; Lisa M Muglia; Gloria Laryea; Louis J Muglia
Journal:  Neuropsychopharmacology       Date:  2015-07-20       Impact factor: 7.853

5.  A single-cell transcriptomic and anatomic atlas of mouse dorsal raphe Pet1 neurons.

Authors:  Benjamin W Okaty; Nikita Sturrock; Yasmin Escobedo Lozoya; YoonJeung Chang; Rebecca A Senft; Krissy A Lyon; Olga V Alekseyenko; Susan M Dymecki
Journal:  Elife       Date:  2020-06-22       Impact factor: 8.140

6.  Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.

Authors:  Jeanine Jochems; Sarah L Teegarden; Yong Chen; Janette Boulden; Collin Challis; Gabriel A Ben-Dor; Sangwon F Kim; Olivier Berton
Journal:  Biol Psychiatry       Date:  2014-08-28       Impact factor: 13.382

Review 7.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

Review 8.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

9.  Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice.

Authors:  Tingting Di; Suyun Zhang; Juan Hong; Tingting Zhang; Ling Chen
Journal:  Front Mol Neurosci       Date:  2017-09-06       Impact factor: 5.639

10.  Regulatory Mechanisms Controlling Maturation of Serotonin Neuron Identity and Function.

Authors:  William C Spencer; Evan S Deneris
Journal:  Front Cell Neurosci       Date:  2017-07-19       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.